LR

Lars Röse

BH Bayer Healthcare: 8 patents #1,173 of 8,007Top 15%
BP Bayer Pharma: 7 patents #125 of 819Top 20%
DK Deutsches Krebsforschungszentrum: 6 patents #13 of 345Top 4%
CO Compugen: 1 patents #95 of 181Top 55%
Overall (All Time): #544,742 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11951166 Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer Sabine Hoff, Dieter Zopf, Fabian Kiessling, Wiltrud LEDERLE, Dennis DOLESCHEL 2024-04-09
11795164 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer Ilona GUTCHER, Norbert Schmees, Benjamin Bader, Christina KOBER, Rafael CARRETERO +3 more 2023-10-24
11655297 ILDR2 antagonists and combinations thereof Uwe Gritzan, Julia Hütter, Spencer Liang, Andrew James Pow, John Hunter +2 more 2023-05-23
11591311 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides Ilona GUTCHER, Ulrike Röhn, Ludwig Zorn, Benjamin Bader, Christina KOBER +3 more 2023-02-28
11524944 2-phenylpyrimidine-4-carboxamides as AHR inhibitors Julien LEFRANC, Norbert Schmees, Ulrike Röhn, Ludwig Zorn, Judith Günther +4 more 2022-12-13
11517622 Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer Sabine Hoff, Dieter Zopf, Fabian Kiessling, Wiltrud LEDERLE, Dennis DOLESCHEL 2022-12-06
11459312 Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides Ludwig Zorn, Ulrike Röhn, Ilona GUTCHER, Benjamin Bader, Christina KOBER +3 more 2022-10-04
11304946 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists Julien LEFRANC, Norbert Schmees, Ulrike Röhn, Ludwig Zorn, Judith Günther +4 more 2022-04-19
11040035 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides Norbert Schmees, Ilona GUTCHER, Horst IRLBACHER, Benjamin Bader, Na Zhao +4 more 2021-06-22